Cibinetide Powder GMP Synthetic Neuroprotective Peptide for Retinal Injury and Neuroinflammation Research | COA Verified Bulk API from China

Key Product Highlights:

Neuro- and retina-targeted regulatory peptide
Reduces neuronal apoptosis and protects retinal pigment epithelial cells
Modulates inflammatory signaling in ocular and neural systems
Improves retinal microvascular perfusion and neurotrophic balance
Reduces oxidative stress–induced cellular damage
Suitable for in vitro, in vivo, and ophthalmic disease models

What is Cibinetide Powder and how is it used in neurological and retinal research?

Cibinetide Powder is a synthetic 11-amino-acid peptide derived from an erythropoietin receptor–associated signaling mechanism. It is widely used in retinal degeneration, optic nerve injury, and neuroinflammation research.

It selectively interacts with receptors on neuronal cells and retinal pigment epithelial cells, regulating oxidative stress responses, apoptosis pathways, and inflammatory signaling in a coordinated manner.

The product is manufactured under strict GMP conditions using solid-phase peptide synthesis (SPPS), followed by multi-step HPLC purification and full mass spectrometry validation to ensure structural accuracy and high purity.

What does the COA of Cibinetide Powder include?

Item	Specification	Result
Appearance	White to off White powder	Consistent
Purity(HPLC)	≥98%	99.22%
MS	Consistent	Consistent
Conclusion	The product complies with the requirements

What are the key advantages of Cibinetide Powder in research applications?

Dual targeting of retinal and neuronal cell systems
Reduced variability in neurodegeneration models
Low cytotoxicity for long-term in vivo studies
Improves retinal microvascular perfusion under ischemic conditions
Cost-effective China-based bulk supply for research procurement

What pharmacological pathways does Cibinetide Powder regulate?

Regulates apoptosis and oxidative stress signaling pathways
Modulates inflammatory responses in ocular and neural systems
Enhances cell survival signaling in retinal tissues
Improves microvascular perfusion and tissue oxygenation

In which research fields is Cibinetide Powder commonly used?

Retinal pigment epithelial and optic nerve degeneration studies
Diabetic retinopathy and ischemic retinal injury models
Neuroinflammation and peripheral neuropathy research
Oxidative stress and cellular aging in neural tissues
Neuroprotective drug development
Preclinical ophthalmic pharmacology evaluation

Why choose GMP-manufactured Cibinetide Powder from China?

Advanced solid-phase peptide synthesis (SPPS) platform
Multi-step HPLC purification ensuring ≥98% purity
Strict control of impurities and by-products
Excellent batch-to-batch consistency
Full documentation: COA, HPLC, MS reports
Flexible supply from milligram to gram scale

What is the mechanism of action of Cibinetide Powder?

Cibinetide acts through two primary biological pathways:

1. Apoptosis and Oxidative Stress Regulation Pathway

It binds to specific receptors on retinal and neuronal cells, downregulating pro-apoptotic signaling while enhancing endogenous antioxidant defense systems, thereby protecting cells from oxidative damage.

2. Inflammation and Microvascular Regulation Pathway

It suppresses excessive inflammatory cytokine release, improves local microvascular perfusion, and enhances oxygen delivery in ocular and neural tissues, maintaining overall tissue homeostasis.

How is quality assurance ensured for Cibinetide Powder under GMP standards?

GMP-certified cleanroom manufacturing environment
HPLC purity and MS identity verification for every batch
Endotoxin, microbial, and moisture testing
Full traceability from raw materials to finished product
Strict QA/QC release procedures prior to shipment

FAQ

1. How long does it take Cibinetide Powder (Ara 290) to work?

Initial pain relief can appear within 24–72 hours after the first dose, while measurable nerve regeneration and full therapeutic benefits usually develop with consistent dosing over 4–8 weeks.

2. Is the Cibinetide Powder (ARA 290) FDA approved?

ARA 290 (Cibinetide) is only available for laboratory and preclinical research use at present, and has not obtained FDA approval for clinical therapeutic applications.

3. Is Cibinetide Powder (Ara290) safe?

It shows good biocompatibility in research trials. Mild, transient injection site reactions are the most common adverse responses, while severe adverse events occur rarely under standard experimental dosage ranges.

4. What are the benefits of Cibinetide Powder( ARA 290)?

It supports small nerve fiber regeneration, eases neuropathic discomfort, modulates local inflammation, reduces oxidative stress, and improves microcirculation in neural and ocular tissues for research models.